TerminatedNot applicableNCT03121599

18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms

Studying Essential thrombocythemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hamad Medical Corporation
Principal Investigator
Mohamed Yassin
Hamad Medical Corporation
Intervention
Diagnostic (18F-FLT PET/CT)(device)
Enrollment
3 enrolled
Eligibility
14-18 years · All sexes
Timeline
2017 – 2018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03121599 on ClinicalTrials.gov

Other trials for Essential thrombocythemia

Additional recruiting or active studies for the same condition.

See all trials for Essential thrombocythemia →

← Back to all trials